Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
NeuroMolecular Medicine
Published in: NeuroMolecular Medicine 2/2014

01-06-2014 | Review Paper

Rett Syndrome and MeCP2

Authors: Vichithra R. B. Liyanage, Mojgan Rastegar

Published in: NeuroMolecular Medicine | Issue 2/2014

Login to get access

Abstract

Rett syndrome (RTT) is a severe and progressive neurological disorder, which mainly affects young females. Mutations of the methyl-CpG binding protein 2 (MECP2) gene are the most prevalent cause of classical RTT cases. MECP2 mutations or altered expression are also associated with a spectrum of neurodevelopmental disorders such as autism spectrum disorders with recent links to fetal alcohol spectrum disorders. Collectively, MeCP2 relation to these neurodevelopmental disorders highlights the importance of understanding the molecular mechanisms by which MeCP2 impacts brain development, mental conditions, and compromised brain function. Since MECP2 mutations were discovered to be the primary cause of RTT, a significant progress has been made in the MeCP2 research, with respect to the expression, function and regulation of MeCP2 in the brain and its contribution in RTT pathogenesis. To date, there have been intensive efforts in designing effective therapeutic strategies for RTT benefiting from mouse models and cells collected from RTT patients. Despite significant progress in MeCP2 research over the last few decades, there is still a knowledge gap between the in vitro and in vivo research findings and translating these findings into effective therapeutic interventions in human RTT patients. In this review, we will provide a synopsis of Rett syndrome as a severe neurological disorder and will discuss the role of MeCP2 in RTT pathophysiology.
Literature
Abuhatzira, L., Makedonski, K., Kaufman, Y., Razin, A., & Shemer, R. (2007). MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production. Epigenetics, 2(4), 214–222.PubMed
Abuhatzira, L., Shamir, A., Schones, D. E., Schaffer, A. A., & Bustin, M. (2011). The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice. Journal of Biological Chemistry, 286(49), 42051–42062. doi:10.​1074/​jbc.​M111.​300541.PubMedCentralPubMed
Adachi, M., Keefer, E. W., & Jones, F. S. (2005). A segment of the Mecp2 promoter is sufficient to drive expression in neurons. Human Molecular Genetics, 14(23), 3709–3722. doi:10.​1093/​hmg/​ddi402.PubMed
Adams, V. H., McBryant, S. J., Wade, P. A., Woodcock, C. L., & Hansen, J. C. (2007). Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. Journal of Biological Chemistry, 282(20), 15057–15064. doi:10.​1074/​jbc.​M700855200.PubMed
Agarwal, N., Becker, A., Jost, K. L., Haase, S., Thakur, B. K., Brero, A., et al. (2011). MeCP2 Rett mutations affect large scale chromatin organization. Human Molecular Genetics, 20(21), 4187–4195. doi:10.​1093/​hmg/​ddr346.PubMed
Akhtar, M. W., Raingo, J., Nelson, E. D., Montgomery, R. L., Olson, E. N., Kavalali, E. T., et al. (2009). Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. Journal of Neuroscience, 29(25), 8288–8297. doi:10.​1523/​JNEUROSCI.​0097-09.​2009.PubMedCentralPubMed
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23(2), 185–188. doi:10.​1038/​13810.PubMed
Amir, R. E., & Zoghbi, H. Y. (2000). Rett syndrome: Methyl-CpG-binding protein 2 mutations and phenotype–genotype correlations. American Journal of Medical Genetics, 97(2), 147–152.PubMed
Asaka, Y., Jugloff, D. G., Zhang, L., Eubanks, J. H., & Fitzsimonds, R. M. (2006). Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiology of Diseases, 21(1), 217–227. doi:10.​1016/​j.​nbd.​2005.​07.​005.
Barber, B. A., Liyanage, V. R., Zachariah, R. M., Olson, C. O., Bailey, M. A., & Rastegar, M. (2013). Dynamic expression of MEIS1 homeoprotein in E14.5 forebrain and differentiated forebrain-derived neural stem cells. Annals of Anatomy, 195(5), 431–440. doi:10.​1016/​j.​aanat.​2013.​04.​005.PubMed
Bartholdi, D., Klein, A., Weissert, M., Koenig, N., Baumer, A., Boltshauser, E., et al. (2006). Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene. Clinical Genetics, 69(4), 319–326. doi:10.​1111/​j.​1399-0004.​2006.​00604.​x.PubMed
Belichenko, N. P., Belichenko, P. V., & Mobley, W. C. (2009a). Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Neurobiology of Diseases, 34(1), 71–77. doi:10.​1016/​j.​nbd.​2008.​12.​016.
Belichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., et al. (2009b). Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: Evidence for disruption of neuronal networks. Journal of Comparative Neurology, 514(3), 240–258. doi:10.​1002/​cne.​22009.PubMed
Bernard, D., Gil, J., Dumont, P., Rizzo, S., Monte, D., Quatannens, B., et al. (2006). The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene, 25(9), 1358–1366. doi:10.​1038/​sj.​onc.​1209179.PubMed
Beyer, K. S., Blasi, F., Bacchelli, E., Klauck, S. M., Maestrini, E., & Poustka, A. (2002). Mutation analysis of the coding sequence of the MECP2 gene in infantile autism. Human Genetics, 111(4–5), 305–309. doi:10.​1007/​s00439-002-0786-3.PubMed
Bienvenu, T., Carrie, A., de Roux, N., Vinet, M. C., Jonveaux, P., Couvert, P., et al. (2000). MECP2 mutations account for most cases of typical forms of Rett syndrome. Human Molecular Genetics, 9(9), 1377–1384.PubMed
Bodda, C., Tantra, M., Mollajew, R., Arunachalam, J. P., Laccone, F. A., Can, K., et al. (2013). Mild overexpression of Mecp2 in mice causes a higher susceptibility toward seizures. American Journal of Pathology, 183(1), 195–210. doi:10.​1016/​j.​ajpath.​2013.​03.​019.PubMed
Brady, M. L., Diaz, M. R., Iuso, A., Everett, J. C., Valenzuela, C. F., & Caldwell, K. K. (2013). Moderate prenatal alcohol exposure reduces plasticity and alters NMDA receptor subunit composition in the dentate gyrus. Journal of Neuroscience, 33(3), 1062–1067. doi:10.​1523/​JNEUROSCI.​1217-12.​2013.PubMedCentralPubMed
Brendel, C., Belakhov, V., Werner, H., Wegener, E., Gartner, J., Nudelman, I., et al. (2011). Readthrough of nonsense mutations in Rett syndrome: Evaluation of novel aminoglycosides and generation of a new mouse model. Journal of Molecular Medicine (Berlin), 89(4), 389–398. doi:10.​1007/​s00109-010-0704-4.
Brero, A., Easwaran, H. P., Nowak, D., Grunewald, I., Cremer, T., Leonhardt, H., et al. (2005). Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. Journal of Cell Biology, 169(5), 733–743. doi:10.​1083/​jcb.​200502062.PubMedCentralPubMed
Buchthal, B., Lau, D., Weiss, U., Weislogel, J. M., & Bading, H. (2012). Nuclear calcium signaling controls methyl-CpG-binding protein 2 (MeCP2) phosphorylation on serine 421 following synaptic activity. Journal of Biological Chemistry, 287(37), 30967–30974. doi:10.​1074/​jbc.​M112.​382507.PubMedCentralPubMed
Budden, S. S., & Gunness, M. E. (2003). Possible mechanisms of osteopenia in Rett syndrome: Bone histomorphometric studies. Journal of Child Neurology, 18(10), 698–702.PubMed
Burmistrova, O. A., Goltsov, A. Y., Abramova, L. I., Kaleda, V. G., Orlova, V. A., & Rogaev, E. I. (2007). MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11). Biochemistry (Moscow), 72(5), 578–582.
Calfa, G., Percy, A. K., & Pozzo-Miller, L. (2011). Experimental models of Rett syndrome based on Mecp2 dysfunction. Experimental Biology and Medicine (Maywood), 236(1), 3–19. doi:10.​1258/​ebm.​2010.​010261.
Carney, R. M., Wolpert, C. M., Ravan, S. A., Shahbazian, M., Ashley-Koch, A., Cuccaro, M. L., et al. (2003). Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatric Neurology, 28(3), 205–211.PubMed
Carter, P., Downs, J., Bebbington, A., Williams, S., Jacoby, P., Kaufmann, W. E., et al. (2010). Stereotypical hand movements in 144 subjects with Rett syndrome from the population-based Australian database. Movement Disorders, 25(3), 282–288. doi:10.​1002/​mds.​22851.PubMed
Chadwick, L. H., & Wade, P. A. (2007). MeCP2 in Rett syndrome: Transcriptional repressor or chromatin architectural protein? Current Opinion in Genetics & Development, 17(2), 121–125. doi:10.​1016/​j.​gde.​2007.​02.​003.
Chao, H. T., Chen, H., Samaco, R. C., Xue, M., Chahrour, M., Yoo, J., et al. (2010). Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature, 468(7321), 263–269. doi:10.​1038/​nature09582.PubMedCentralPubMed
Chapleau, C. A., Calfa, G. D., Lane, M. C., Albertson, A. J., Larimore, J. L., Kudo, S., et al. (2009). Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations. Neurobiology of Diseases, 35(2), 219–233. doi:10.​1016/​j.​nbd.​2009.​05.​001.
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001). Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nature Genetics, 27(3), 327–331. doi:10.​1038/​85906.PubMed
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., et al. (2003). Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302(5646), 885–889. doi:10.​1126/​science.​1086446.PubMed
Cheng, J., Huang, M., Zhu, Y., Xin, Y. J., Zhao, Y. K., Huang, J., et al. (2013). SUMOylation of MeCP2 is essential for transcriptional repression and hippocampal synapse development. Journal of Neurochemistry,. doi:10.​1111/​jnc.​12523.
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., et al. (2009). Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science, 325(5942), 834–840. doi:10.​1126/​science.​1175371.PubMed
Christodoulou, J., Grimm, A., Maher, T., & Bennetts, B. (2003). RettBASE: The IRSA MECP2 variation database—A new mutation database in evolution. Human Mutation, 21(5), 466–472. doi:10.​1002/​humu.​10194.PubMed
Cirignotta, F., Lugaresi, E., & Montagna, P. (1986). Breathing impairment in Rett syndrome. American Journal of Medical Genetics, Supplement 1, 167–173.
Cohen, D., Lazar, G., Couvert, P., Desportes, V., Lippe, D., Mazet, P., et al. (2002). MECP2 mutation in a boy with language disorder and schizophrenia. American Journal of Psychiatry, 159(1), 148–149.PubMed
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., et al. (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Human Molecular Genetics, 13(21), 2679–2689. doi:10.​1093/​hmg/​ddh282.PubMed
Coutinho, A. M., Oliveira, G., Katz, C., Feng, J., Yan, J., Yang, C., et al. (2007). MECP2 coding sequence and 3′UTR variation in 172 unrelated autistic patients. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(4), 475–483. doi:10.​1002/​ajmg.​b.​30490.
Coy, J. F., Sedlacek, Z., Bachner, D., Delius, H., & Poustka, A. (1999). A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3″-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Human Molecular Genetics, 8(7), 1253–1262.PubMed
Craig, J. M., Earle, E., Canham, P., Wong, L. H., Anderson, M., & Choo, K. H. (2003). Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns. Human Molecular Genetics, 12(23), 3109–3121. doi:10.​1093/​hmg/​ddg330.PubMed
Cusack, S. M., Rohn, T. T., Medeck, R. J., Irwin, K. M., Brown, R. J., Mercer, L. M., et al. (2004). Suppression of MeCP2β expression inhibits neurite extension in PC12 cells. Experimental Cell Research, 299(2), 442–453. doi:10.​1016/​j.​yexcr.​2004.​05.​035.PubMed
De Felice, C., Signorini, C., Durand, T., Ciccoli, L., Leoncini, S., D’Esposito, M., et al. (2012). Partial rescue of Rett syndrome by omega-3 polyunsaturated fatty acids (PUFAs) oil. Genes & Nutrition, 7(3), 447–458. doi:10.​1007/​s12263-012-0285-7.
Deogracias, R., Yazdani, M., Dekkers, M. P., Guy, J., Ionescu, M. C., Vogt, K. E., et al. (2012). Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences USA, 109(35), 14230–14235. doi:10.​1073/​pnas.​1206093109.
Dephoure, N., Zhou, C., Villen, J., Beausoleil, S. A., Bakalarski, C. E., Elledge, S. J., et al. (2008). A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Sciences USA, 105(31), 10762–10767. doi:10.​1073/​pnas.​0805139105.
D’Esposito, M., Quaderi, N. A., Ciccodicola, A., Bruni, P., Esposito, T., D’Urso, M., et al. (1996). Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mammalian Genome, 7(7), 533–535.PubMed
Dragich, J. M., Kim, Y. H., Arnold, A. P., & Schanen, N. C. (2007). Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. Journal of Comparative Neurology, 501(4), 526–542. doi:10.​1002/​cne.​21264.PubMed
Ebert, D. H., Gabel, H. W., Robinson, N. D., Kastan, N. R., Hu, L. S., Cohen, S., et al. (2013). Activity-dependent phosphorylation of MECP2 threonine 308 regulates interaction with NcoR. Nature,. doi:10.​1038/​nature12348.PubMedCentral
Evans, J. C., Archer, H. L., Colley, J. P., Ravn, K., Nielsen, J. B., Kerr, A., et al. (2005a). Early onset seizures and Rett-like features associated with mutations in CDKL5. European Journal of Human Genetics, 13(10), 1113–1120. doi:10.​1038/​sj.​ejhg.​5201451.PubMed
Evans, J. C., Archer, H. L., Whatley, S. D., Kerr, A., Clarke, A., & Butler, R. (2005b). Variation in exon 1 coding region and promoter of MECP2 in Rett syndrome and controls. European Journal of Human Genetics, 13(1), 124–126. doi:10.​1038/​sj.​ejhg.​5201270.PubMed
Ezeonwuka, C., & Rastegar, M. (2014). MeCP2-related diseases and animal models. Diseases, 2(1), 45–70.
Fichou, Y., Nectoux, J., Bahi-Buisson, N., Rosas-Vargas, H., Girard, B., Chelly, J., et al. (2009). The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform. Neurogenetics, 10(2), 127–133. doi:10.​1007/​s10048-008-0161-1.PubMed
Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K., & Goto, Y. (2005). Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. Journal of Neuropathology and Experimental Neurology, 64(6), 537–544.PubMed
Fukushige, S., & Horii, A. (2013). DNA methylation in cancer: A gene silencing mechanism and the clinical potential of its biomarkers. Tohoku Journal of Experimental Medicine, 229(3), 173–185.PubMed
Fyffe, S. L., Neul, J. L., Samaco, R. C., Chao, H. T., Ben-Shachar, S., Moretti, P., et al. (2008). Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress. Neuron, 59(6), 947–958. doi:10.​1016/​j.​neuron.​2008.​07.​030.PubMedCentralPubMed
Garg, S. K., Lioy, D. T., Cheval, H., McGann, J. C., Bissonnette, J. M., Murtha, M. J., et al. (2013). Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. Journal of Neuroscience, 33(34), 13612–13620. doi:10.​1523/​JNEUROSCI.​1854-13.​2013.PubMedCentralPubMed
Gemelli, T., Berton, O., Nelson, E. D., Perrotti, L. I., Jaenisch, R., & Monteggia, L. M. (2006). Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Biological Psychiatry, 59(5), 468–476. doi:10.​1016/​j.​biopsych.​2005.​07.​025.PubMed
Georgel, P. T., Horowitz-Scherer, R. A., Adkins, N., Woodcock, C. L., Wade, P. A., & Hansen, J. C. (2003). Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. Journal of Biological Chemistry, 278(34), 32181–32188. doi:10.​1074/​jbc.​M305308200.PubMed
Ghosh, R. P., Horowitz-Scherer, R. A., Nikitina, T., Shlyakhtenko, L. S., & Woodcock, C. L. (2010a). MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Molecular and Cellular Biology, 30(19), 4656–4670. doi:10.​1128/​MCB.​00379-10.PubMedCentralPubMed
Ghosh, R. P., Nikitina, T., Horowitz-Scherer, R. A., Gierasch, L. M., Uversky, V. N., Hite, K., et al. (2010b). Unique physical properties and interactions of the domains of methylated DNA binding protein 2. Biochemistry, 49(20), 4395–4410. doi:10.​1021/​bi9019753.PubMedCentralPubMed
Giacometti, E., Luikenhuis, S., Beard, C., & Jaenisch, R. (2007). Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proceedings of the National Academy of Sciences USA, 104(6), 1931–1936. doi:10.​1073/​pnas.​0610593104.
Gianakopoulos, P. J., Zhang, Y., Pencea, N., Orlic-Milacic, M., Mittal, K., Windpassinger, C., et al. (2012). Mutations in MECP2 exon 1 in classical Rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 159B(2), 210–216. doi:10.​1002/​ajmg.​b.​32015.
Gillberg, C. (1986). Autism and Rett syndrome: Some notes on differential diagnosis. American Journal of Medical Genetics, Supplement 1, 127–131.
Gonzales, M. L., Adams, S., Dunaway, K. W., & LaSalle, J. M. (2012). Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation. Molecular and Cellular Biology, 32(14), 2894–2903. doi:10.​1128/​MCB.​06728-11.PubMedCentralPubMed
Guideri, F., Acampa, M., Blardi, P., de Lalla, A., Zappella, M., & Hayek, Y. (2004). Cardiac dysautonomia and serotonin plasma levels in Rett syndrome. Neuropediatrics, 35(1), 36–38. doi:10.​1055/​s-2004-815789.PubMed
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001). A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nature Genetics, 27(3), 322–326. doi:10.​1038/​85899.PubMed
Hagberg, B. (2002). Clinical manifestations and stages of Rett syndrome. Mental Retardation and Developmental Disabilities, 8(2), 61–65. doi:10.​1002/​mrdd.​10020.
Hagberg, B., Aicardi, J., Dias, K., & Ramos, O. (1983). A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: Report of 35 cases. Annals of Neurology, 14(4), 471–479. doi:10.​1002/​ana.​410140412.PubMed
Hagebeuk, E. E., Koelman, J. H., Duran, M., Abeling, N. G., Vyth, A., & Poll-The, B. T. (2011). Clinical and electroencephalographic effects of folinic acid treatment in Rett syndrome patients. Journal of Child Neurology, 26(6), 718–723. doi:10.​1177/​0883073810390037​.PubMed
Han, K., Gennarino, V. A., Lee, Y., Pang, K., Hashimoto-Torii, K., Choufani, S., et al. (2013). Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes & Development, 27(5), 485–490. doi:10.​1101/​gad.​207456.​112.
Heilstedt, H. A., Shahbazian, M. D., & Lee, B. (2002). Infantile hypotonia as a presentation of Rett syndrome. American Journal of Medical Genetics, 111(3), 238–242. doi:10.​1002/​ajmg.​10633.PubMed
Hite, K. C., Kalashnikova, A. A., & Hansen, J. C. (2012). Coil-to-helix transitions in intrinsically disordered methyl CpG binding protein 2 and its isolated domains. Protein Science, 21(4), 531–538. doi:10.​1002/​pro.​2037.PubMedCentralPubMed
Hoffbuhr, K., Devaney, J. M., LaFleur, B., Sirianni, N., Scacheri, C., Giron, J., et al. (2001). MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology, 56(11), 1486–1495.PubMed
Hoffbuhr, K. C., Moses, L. M., Jerdonek, M. A., Naidu, S., & Hoffman, E. P. (2002). Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Mental Retardation and Developmental Disabilities Research Reviews, 8(2), 99–105. doi:10.​1002/​mrdd.​10026.PubMed
Holm, V. A., & King, H. A. (1990). Scoliosis in the Rett syndrome. Brain Development, 12(1), 151–153.PubMed
Horike, S., Cai, S., Miyano, M., Cheng, J. F., & Kohwi-Shigematsu, T. (2005). Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nature Genetics, 37(1), 31–40. doi:10.​1038/​ng1491.PubMed
Hung, M. S., & Shen, C. K. (2003). Eukaryotic methyl-CpG-binding domain proteins and chromatin modification. Eukaryotic Cell, 2(5), 841–846.PubMedCentralPubMed
Huppke, P., Ohlenbusch, A., Brendel, C., Laccone, F., & Gartner, J. (2005). Mutation analysis of the HDAC 1, 2, 8 and CDKL5 genes in Rett syndrome patients without mutations in MECP2. American Journal of Medical Genetics Part A, 137(2), 136–138. doi:10.​1002/​ajmg.​a.​30764.PubMed
Im, H. I., Hollander, J. A., Bali, P., & Kenny, P. J. (2010). MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nature Neuroscience, 13(9), 1120–1127. doi:10.​1038/​nn.​2615.PubMedCentralPubMed
Isaacs, J. S., Murdock, M., Lane, J., & Percy, A. K. (2003). Eating difficulties in girls with Rett syndrome compared with other developmental disabilities. Journal of the American Dietetic Association, 103(2), 224–230. doi:10.​1053/​jada.​2003.​50026.PubMed
Ishii, T., Makita, Y., Ogawa, A., Amamiya, S., Yamamoto, M., Miyamoto, A., et al. (2001). The role of different X-inactivation pattern on the variable clinical phenotype with Rett syndrome. Brain Development, 23(Suppl 1), S161–S164.PubMed
Itoh, M., Tahimic, C. G., Ide, S., Otsuki, A., Sasaoka, T., Noguchi, S., et al. (2012). Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development. Journal of Biological Chemistry, 287(17), 13859–13867. doi:10.​1074/​jbc.​M111.​309864.PubMedCentralPubMed
Jan, M. M., Dooley, J. M., & Gordon, K. E. (1999). Male Rett syndrome variant: Application of diagnostic criteria. Pediatric Neurology, 20(3), 238–240.PubMed
Jentarra, G. M., Olfers, S. L., Rice, S. G., Srivastava, N., Homanics, G. E., Blue, M., et al. (2010). Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neuroscience, 11, 19. doi:10.​1186/​1471-2202-11-19.PubMedCentralPubMed
Jugloff, D. G., Vandamme, K., Logan, R., Visanji, N. P., Brotchie, J. M., & Eubanks, J. H. (2008). Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Human Molecular Genetics, 17(10), 1386–1396. doi:10.​1093/​hmg/​ddn026.PubMed
Julu, P. O., Kerr, A. M., Hansen, S., Apartopoulos, F., & Jamal, G. A. (1997). Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett’s syndrome. Archives of Disease in Childhood, 77(5), 464–465.PubMed
Katz, D. M., Dutschmann, M., Ramirez, J. M., & Hilaire, G. (2009). Breathing disorders in Rett syndrome: Progressive neurochemical dysfunction in the respiratory network after birth. Respiratory Physiology & Neurobiology, 168(1–2), 101–108. doi:10.​1016/​j.​resp.​2009.​04.​017.
Kernohan, K. D., Jiang, Y., Tremblay, D. C., Bonvissuto, A. C., Eubanks, J. H., Mann, M. R., et al. (2010). ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. Developmental Cell, 18(2), 191–202. doi:10.​1016/​j.​devcel.​2009.​12.​017.PubMed
Kerr, B., Soto, C. J., Saez, M., Abrams, A., Walz, K., & Young, J. I. (2012). Transgenic complementation of MeCP2 deficiency: Phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. European Journal of Human Genetics, 20(1), 69–76. doi:10.​1038/​ejhg.​2011.​145.PubMedCentralPubMed
Kim, K. Y., Hysolli, E., & Park, I. H. (2011). Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proceedings of the National Academy of Sciences USA, 108(34), 14169–14174. doi:10.​1073/​pnas.​1018979108.
Kim, P., Park, J. H., Choi, C. S., Choi, I., Joo, S. H., Kim, M. K., et al. (2013). Effects of ethanol exposure during early pregnancy in hyperactive, inattentive and impulsive behaviors and MeCP2 expression in rodent offspring. Neurochemical Research, 38(3), 620–631. doi:10.​1007/​s11064-012-0960-5.PubMed
Kim, B., Rincon Castro, L. M., Jawed, S., & Niles, L. P. (2008). Clinically relevant concentrations of valproic acid modulate melatonin MT(1) receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells. European Journal of Pharmacology, 589(1–3), 45–48. doi:10.​1016/​j.​ejphar.​2008.​04.​058.PubMed
Kishi, N., & Macklis, J. D. (2004). MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Molecular and Cellular Neuroscience, 27(3), 306–321. doi:10.​1016/​j.​mcn.​2004.​07.​006.PubMed
Klauck, S. M., Lindsay, S., Beyer, K. S., Splitt, M., Burn, J., & Poustka, A. (2002). A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. American Journal of Human Genetics, 70(4), 1034–1037. doi:10.​1086/​339553.PubMedCentralPubMed
Klein, M. E., Lioy, D. T., Ma, L., Impey, S., Mandel, G., & Goodman, R. H. (2007). Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nature Neuroscience, 10(12), 1513–1514. doi:10.​1038/​nn2010.PubMed
Kondo, M., Gray, L. J., Pelka, G. J., Christodoulou, J., Tam, P. P., & Hannan, A. J. (2008). Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome–Mecp2 gene dosage effects and BDNF expression. European Journal of Neuroscience, 27(12), 3342–3350. doi:10.​1111/​j.​1460-9568.​2008.​06305.​x.PubMed
Kudo, S., Nomura, Y., Segawa, M., Fujita, N., Nakao, M., Hammer, S., et al. (2002). Functional characterisation of MeCP2 mutations found in male patients with X linked mental retardation. Journal of Medical Genetics, 39(2), 132–136.PubMedCentralPubMed
Kudo, S., Nomura, Y., Segawa, M., Fujita, N., Nakao, M., Schanen, C., et al. (2003). Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. Journal of Medical Genetics, 40(7), 487–493.PubMedCentralPubMed
Kuhn, D. E., Nuovo, G. J., Terry, A. V, Jr, Martin, M. M., Malana, G. E., Sansom, S. E., et al. (2010). Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. Journal of Biological Chemistry, 285(2), 1529–1543. doi:10.​1074/​jbc.​M109.​033407.PubMedCentralPubMed
Kumar, A., Kamboj, S., Malone, B. M., Kudo, S., Twiss, J. L., Czymmek, K. J., et al. (2008). Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo. Journal of Cell Science, 121(Pt 7), 1128–1137. doi:10.​1242/​jcs.​016865.PubMedCentralPubMed
Kuwano, Y., Kamio, Y., Kawai, T., Katsuura, S., Inada, N., Takaki, A., et al. (2011). Autism-associated gene expression in peripheral leucocytes commonly observed between subjects with autism and healthy women having autistic children. PLoS ONE, 6(9), e24723. doi:10.​1371/​journal.​pone.​0024723.PubMedCentralPubMed
Lam, C. W., Yeung, W. L., Ko, C. H., Poon, P. M., Tong, S. F., Chan, K. Y., et al. (2000). Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. Journal of Medical Genetics, 37(12), E41.PubMedCentralPubMed
Larimore, J. L., Chapleau, C. A., Kudo, S., Theibert, A., Percy, A. K., & Pozzo-Miller, L. (2009). Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations. Neurobiology of Diseases, 34(2), 199–211. doi:10.​1016/​j.​nbd.​2008.​12.​011.
Lewis, C. R., Staudinger, K., Scheck, L., & Olive, M. F. (2013). The effects of maternal separation on adult methamphetamine self-administration, extinction, reinstatement, and MeCP2 immunoreactivity in the nucleus accumbens. Frontiers in Psychiatry, 4, 55. doi:10.​3389/​fpsyt.​2013.​00055.PubMedCentralPubMed
Li, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Loven, J., et al. (2013). Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell, 13(4), 446–458. doi:10.​1016/​j.​stem.​2013.​09.​001.PubMed
Li, H., Zhong, X., Chau, K. F., Williams, E. C., & Chang, Q. (2011). Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory. Nature Neuroscience, 14(8), 1001–1008. doi:10.​1038/​nn.​2866.PubMedCentralPubMed
Liyanage, V. R. B., Zachariah, R. M., Delcuve, G. P., Davie, J. R., & Rastegar, M. (2012). New developments in chromatin research: An epigenetic perspective. In N. M. Simpson & V. J. Stewart (Eds.), New developments in chromatin research (pp. 29–58). New York: Nova Science.
Liyanage, V., Zachariah, R., & Rastegar, M. (2013). Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Molecular Autism, 4(1), 46. doi:10.​1186/​2040-2392-4-46.PubMedCentralPubMed
Loat, C. S., Curran, S., Lewis, C. M., Duvall, J., Geschwind, D., Bolton, P., et al. (2008). Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism. Genes, Brain and Behavior, 7(7), 754–760. doi:10.​1111/​j.​1601-183X.​2008.​00414.​x.
Lonetti, G., Angelucci, A., Morando, L., Boggio, E. M., Giustetto, M., & Pizzorusso, T. (2010). Early environmental enrichment moderates the behavioral and synaptic phenotype of MeCP2 null mice. Biological Psychiatry, 67(7), 657–665. doi:10.​1016/​j.​biopsych.​2009.​12.​022.PubMed
Luikenhuis, S., Giacometti, E., Beard, C. F., & Jaenisch, R. (2004). Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proceedings of the National Academy of Sciences USA, 101(16), 6033–6038. doi:10.​1073/​pnas.​0401626101.
Lusardi, T. A., Farr, C. D., Faulkner, C. L., Pignataro, G., Yang, T., Lan, J., et al. (2010). Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. Journal of Cerebral Blood Flow and Metabolism, 30(4), 744–756. doi:10.​1038/​jcbfm.​2009.​253.PubMedCentralPubMed
Lyst, M. J., Ekiert, R., Ebert, D. H., Merusi, C., Nowak, J., Selfridge, J., et al. (2013). Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nature Neuroscience, 16(7), 898–902. doi:10.​1038/​nn.​3434.PubMed
Madan, N., Levine, M., Pourmoghadam, K., & Sokoloski, M. (2004). Severe sinus bradycardia in a patient with Rett syndrome: A new cause for a pause? Pediatric Cardiology, 25(1), 53–55. doi:10.​1007/​s00246-003-0341-6.PubMed
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., et al. (2003). DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science, 302(5646), 890–893. doi:10.​1126/​science.​1090842.PubMed
Matarazzo, V., Cohen, D., Palmer, A. M., Simpson, P. J., Khokhar, B., Pan, S. J., et al. (2004). The transcriptional repressor Mecp2 regulates terminal neuronal differentiation. Molecular and Cellular Neuroscience, 27(1), 44–58. doi:10.​1016/​j.​mcn.​2004.​05.​005.PubMed
McCauley, M. D., Wang, T., Mike, E., Herrera, J., Beavers, D. L., Huang, T. W., et al. (2011). Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: Implication for therapy in Rett syndrome. Science Translational Medicine, 3(113), 113ra125. doi:10.​1126/​scitranslmed.​3002982.PubMedCentralPubMed
Mirza, S., Sharma, G., Parshad, R., Gupta, S. D., Pandya, P., & Ralhan, R. (2013). Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. Journal of Breast Cancer, 16(1), 23–31. doi:10.​4048/​jbc.​2013.​16.​1.​23.PubMedCentralPubMed
Miyake, K., & Nagai, K. (2007). Phosphorylation of methyl-CpG binding protein 2 (MeCP2) regulates the intracellular localization during neuronal cell differentiation. Neurochemistry International, 50(1), 264–270. doi:10.​1016/​j.​neuint.​2006.​08.​018.PubMed
Miyake, K., Yang, C., Minakuchi, Y., Ohori, K., Soutome, M., Hirasawa, T., et al. (2013). Comparison of genomic and epigenomic expression in monozygotic twins discordant for Rett syndrome. PLoS ONE, 8(6), e66729. doi:10.​1371/​journal.​pone.​0066729.PubMed
Mnatzakanian, G. N., Lohi, H., Munteanu, I., Alfred, S. E., Yamada, T., MacLeod, P. J., et al. (2004). A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nature Genetics, 36(4), 339–341. doi:10.​1038/​ng1327.PubMed
Moog, U., Smeets, E. E., van Roozendaal, K. E., Schoenmakers, S., Herbergs, J., Schoonbrood-Lenssen, A. M., et al. (2003). Neurodevelopmental disorders in males related to the gene causing Rett syndrome in females (MECP2). European Journal of Paediatric Neurology, 7(1), 5–12.PubMed
Morton, R. E., Bonas, R., Minford, J., Kerr, A., & Ellis, R. E. (1997). Feeding ability in Rett syndrome. Developmental Medicine and Child Neurology, 39(5), 331–335.PubMed
Motil, K. J., Caeg, E., Barrish, J. O., Geerts, S., Lane, J. B., Percy, A. K., et al. (2012). Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome. Journal of Pediatric Gastroenterology and Nutrition, 55(3), 292–298. doi:10.​1097/​MPG.​0b013e31824b6159​.PubMedCentralPubMed
Muller, H. M., Fiegl, H., Goebel, G., Hubalek, M. M., Widschwendter, A., Muller-Holzner, E., et al. (2003). MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor status. British Journal of Cancer, 89(10), 1934–1939. doi:10.​1038/​sj.​bjc.​6601392.PubMedCentralPubMed
Murakami, J. W., Courchesne, E., Haas, R. H., Press, G. A., & Yeung-Courchesne, R. (1992). Cerebellar and cerebral abnormalities in Rett syndrome: A quantitative MR analysis. AJR. American Journal of Roentgenology, 159(1), 177–183. doi:10.​2214/​ajr.​159.​1.​1609693.PubMed
Na, E. S., Nelson, E. D., Adachi, M., Autry, A. E., Mahgoub, M. A., Kavalali, E. T., et al. (2012). A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission. Journal of Neuroscience, 32(9), 3109–3117. doi:10.​1523/​JNEUROSCI.​6000-11.​2012.PubMed
Nag, N., Mellott, T. J., & Berger-Sweeney, J. E. (2008). Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome. Brain Research, 1237, 101–109. doi:10.​1016/​j.​brainres.​2008.​08.​042.PubMed
Nagarajan, R. P., Hogart, A. R., Gwye, Y., Martin, M. R., & LaSalle, J. M. (2006). Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation. Epigenetics, 1(4), e1–e11.PubMedCentralPubMed
Nagarajan, R. P., Patzel, K. A., Martin, M., Yasui, D. H., Swanberg, S. E., Hertz-Picciotto, I., et al. (2008). MECP2 promoter methylation and X chromosome inactivation in autism. Autism Research, 1(3), 169–178. doi:10.​1002/​aur.​24.PubMedCentralPubMed
Nan, X., Hou, J., Maclean, A., Nasir, J., Lafuente, M. J., Shu, X., et al. (2007). Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proceedings of the National Academy of Sciences USA, 104(8), 2709–2714. doi:10.​1073/​pnas.​0608056104.
Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., et al. (1998). Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393(6683), 386–389. doi:10.​1038/​30764.PubMed
Newnham, C. M., Hall-Pogar, T., Liang, S., Wu, J., Tian, B., Hu, J., et al. (2010). Alternative polyadenylation of MeCP2: Influence of cis-acting elements and trans-acting factors. RNA Biology, 7(3), 361–372.PubMed
Nguyen, M. V., Du, F., Felice, C. A., Shan, X., Nigam, A., Mandel, G., et al. (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. Journal of Neuroscience, 32(29), 10021–10034. doi:10.​1523/​JNEUROSCI.​1316-12.​2012.PubMedCentralPubMed
Nguyen, M. V., Felice, C. A., Du, F., Covey, M. V., Robinson, J. K., Mandel, G., et al. (2013). Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. Journal of Neuroscience, 33(48), 18764–18774. doi:10.​1523/​JNEUROSCI.​2657-13.​2013.PubMed
Nikitina, T., Ghosh, R. P., Horowitz-Scherer, R. A., Hansen, J. C., Grigoryev, S. A., & Woodcock, C. L. (2007a). MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. Journal of Biological Chemistry, 282(38), 28237–28245. doi:10.​1074/​jbc.​M704304200.PubMed
Nikitina, T., Shi, X., Ghosh, R. P., Horowitz-Scherer, R. A., Hansen, J. C., & Woodcock, C. L. (2007b). Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. Molecular and Cellular Biology, 27(3), 864–877. doi:10.​1128/​MCB.​01593-06.PubMedCentralPubMed
Nomura, T., Kimura, M., Horii, T., Morita, S., Soejima, H., Kudo, S., et al. (2008). MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Human Molecular Genetics, 17(8), 1192–1199. doi:10.​1093/​hmg/​ddn011.PubMed
Nomura, Y., & Segawa, M. (1992). Motor symptoms of the Rett syndrome: Abnormal muscle tone, posture, locomotion and stereotyped movement. Brain & Development, 14(Suppl), S21–S28.
Ogier, M., & Katz, D. M. (2008). Breathing dysfunction in Rett syndrome: Understanding epigenetic regulation of the respiratory network. Respiratory Physiology & Neurobiology, 164(1–2), 55–63. doi:10.​1016/​j.​resp.​2008.​04.​005.
Ogier, M., Wang, H., Hong, E., Wang, Q., Greenberg, M. E., & Katz, D. M. (2007). Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. Journal of Neuroscience, 27(40), 10912–10917. doi:10.​1523/​JNEUROSCI.​1869-07.​2007.PubMed
Olson, C. O., Zachariah, R. M., Ezeonwuka, C. D., Liyanage, V. R. B., & Rastegar, M. (2014). Brain region-specific expression of MeCP2 isoforms correlates with DNA methylation within Mecp2 regulatory elements. PLoS ONE, 9(3), e90645. doi:10.​1371/​journal.​pone.​0090645.
Olsson, B., & Rett, A. (1987). Autism and Rett syndrome: Behavioural investigations and differential diagnosis. Developmental Medicine and Child Neurology, 29(4), 429–441.PubMed
Pelka, G. J., Watson, C. M., Christodoulou, J., & Tam, P. P. (2005). Distinct expression profiles of Mecp2 transcripts with different lengths of 3′UTR in the brain and visceral organs during mouse development. Genomics, 85(4), 441–452. doi:10.​1016/​j.​ygeno.​2004.​12.​002.PubMed
Pelka, G. J., Watson, C. M., Radziewic, T., Hayward, M., Lahooti, H., Christodoulou, J., et al. (2006). Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain, 129(Pt 4), 887–898. doi:10.​1093/​brain/​awl022.PubMed
Petazzi, P., Sandoval, J., Szczesna, K., Jorge, O. C., Roa, L., Sayols, S., et al. (2013). Dysregulation of the long non-coding RNA transcriptome in a Rett syndrome mouse model. RNA Biology, 10(7), 1197–1203. doi:10.​4161/​rna.​24286.PubMedCentralPubMed
Petel-Galil, Y., Benteer, B., Galil, Y. P., Zeev, B. B., Greenbaum, I., Vecsler, M., et al. (2006). Comprehensive diagnosis of Rett’s syndrome relying on genetic, epigenetic and expression evidence of deficiency of the methyl-CpG-binding protein 2 gene: Study of a cohort of Israeli patients. Journal of Medical Genetics, 43(12), e56. doi:10.​1136/​jmg.​2006.​041285.PubMedCentralPubMed
Peters, S. U., Hundley, R. J., Wilson, A. K., Warren, Z., Vehorn, A., Carvalho, C. M., et al. (2013). The behavioral phenotype in MECP2 duplication syndrome: A comparison with idiopathic autism. Autism Research, 6(1), 42–50. doi:10.​1002/​aur.​1262.PubMedCentralPubMed
Philippe, C., Amsallem, D., Francannet, C., Lambert, L., Saunier, A., Verneau, F., et al. (2010). Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. Journal of Medical Genetics, 47(1), 59–65. doi:10.​1136/​jmg.​2009.​067355.PubMed
Pini, G., Scusa, M. F., Congiu, L., Benincasa, A., Morescalchi, P., Bottiglioni, I., et al. (2012). IGF1 as a potential treatment for Rett syndrome: Safety assessment in six Rett patients. Autism Research and Treatment, 2012, 679801. doi:10.​1155/​2012/​679801.PubMedCentralPubMed
Popescu, A. C., Sidorova, E., Zhang, G., & Eubanks, J. H. (2010). Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro. Journal of Neuroscience Research, 88(11), 2316–2324. doi:10.​1002/​jnr.​22409.PubMed
Quenard, A., Yilmaz, S., Fontaine, H., Bienvenu, T., Moncla, A., des Portes, V., et al. (2006). Deleterious mutations in exon 1 of MECP2 in Rett syndrome. European Journal of Medical Genetics, 49(4), 313–322. doi:10.​1016/​j.​ejmg.​2005.​11.​002.PubMed
Ray, B. K., Dhar, S., Henry, C., Rich, A., & Ray, A. (2013). Epigenetic regulation by Z-DNA silencer function controls cancer-associated ADAM-12 expression in breast cancer: Cross-talk between MeCP2 and NF1 transcription factor family. Cancer Research, 73(2), 736–744. doi:10.​1158/​0008-5472.​CAN-12-2601.PubMed
Reeves, R., & Nissen, M. S. (1990). The AT-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. Journal of Biological Chemistry, 265(15), 8573–8582.PubMed
Reichwald, K., Thiesen, J., Wiehe, T., Weitzel, J., Poustka, W. A., Rosenthal, A., et al. (2000). Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mammalian Genome, 11(3), 182–190.PubMed
Reiss, A. L., Faruque, F., Naidu, S., Abrams, M., Beaty, T., Bryan, R. N., et al. (1993). Neuroanatomy of Rett syndrome: A volumetric imaging study. Annals of Neurology, 34(2), 227–234. doi:10.​1002/​ana.​410340220.PubMed
Renieri, A., Meloni, I., Longo, I., Ariani, F., Mari, F., Pescucci, C., et al. (2003). Rett syndrome: The complex nature of a monogenic disease. Journal of Molecular Medicine (Berlin), 81(6), 346–354. doi:10.​1007/​s00109-003-0444-9.
Repunte-Canonigo, V., Chen, J., Lefebvre, C., Kawamura, T., Kreifeldt, M., Basson, O., et al. (2013). MeCP2 regulates ethanol sensitivity and intake. Addiction Biology,. doi:10.​1111/​adb.​12047.PubMed
Rett, A. (1966). On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wiener Medizinische Wochenschrift, 116(37), 723–726.PubMed
Ricceri, L., De Filippis, B., & Laviola, G. (2008). Mouse models of Rett syndrome: From behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behavioural Pharmacology, 19(5–6), 501–517. doi:10.​1097/​FBP.​0b013e32830c3645​.PubMed
Ricciardi, S., Boggio, E. M., Grosso, S., Lonetti, G., Forlani, G., Stefanelli, G., et al. (2011). Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Human Molecular Genetics, 20(6), 1182–1196. doi:10.​1093/​hmg/​ddq563.PubMed
Romano-Lopez, A., Mendez-Diaz, M., Ruiz-Contreras, A. E., Carrisoza, R., & Prospero-Garcia, O. (2012). Maternal separation and proclivity for ethanol intake: A potential role of the endocannabinoid system in rats. Neuroscience, 223, 296–304. doi:10.​1016/​j.​neuroscience.​2012.​07.​071.PubMed
Roze, E., Cochen, V., Sangla, S., Bienvenu, T., Roubergue, A., Leu-Semenescu, S., et al. (2007). Rett syndrome: An overlooked diagnosis in women with stereotypic hand movements, psychomotor retardation, parkinsonism, and dystonia? Movement Disorders, 22(3), 387–389. doi:10.​1002/​mds.​21276.PubMed
Samaco, R. C., Nagarajan, R. P., Braunschweig, D., & LaSalle, J. M. (2004). Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Human Molecular Genetics, 13(6), 629–639. doi:10.​1093/​hmg/​ddh063.PubMed
Sapkota, Y., Robson, P., Lai, R., Cass, C. E., Mackey, J. R., & Damaraju, S. (2012). A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility. European Journal of Human Genetics, 20(6), 682–689. doi:10.​1038/​ejhg.​2011.​273.PubMedCentralPubMed
Saunders, C. J., Minassian, B. E., Chow, E. W., Zhao, W., & Vincent, J. B. (2009). Novel exon 1 mutations in MECP2 implicate isoform MeCP2_e1 in classical Rett syndrome. American Journal of Medical Genetics: Part A, 149A(5), 1019–1023. doi:10.​1002/​ajmg.​a.​32776.
Saxena, A., de Lagarde, D., Leonard, H., Williamson, S. L., Vasudevan, V., Christodoulou, J., et al. (2006). Lost in translation: Translational interference from a recurrent mutation in exon 1 of MECP2. Journal of Medical Genetics, 43(6), 470–477. doi:10.​1136/​jmg.​2005.​036244.PubMedCentralPubMed
Schaevitz, L. R., Gómez, N. B., Zhen, D. P., & Berger-Sweeney, J. E. (2013). MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits. Genes, Brain and Behavior,. doi:10.​1111/​gbb.​12070.
Shahbazian, M. D., Antalffy, B., Armstrong, D. L., & Zoghbi, H. Y. (2002a). Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Human Molecular Genetics, 11(2), 115–124.PubMed
Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., et al. (2002b). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35(2), 243–254.PubMed
Shibayama, A., Cook, E. H, Jr, Feng, J., Glanzmann, C., Yan, J., Craddock, N., et al. (2004). MECP2 structural and 3′-UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 128B(1), 50–53. doi:10.​1002/​ajmg.​b.​30016.
Shu, L., Khor, T. O., Lee, J. H., Boyanapalli, S. S., Huang, Y., Wu, T. Y., et al. (2011). Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS Journal, 13(4), 606–614. doi:10.​1208/​s12248-011-9300-y.PubMedCentralPubMed
Singleton, M. K., Gonzales, M. L., Leung, K. N., Yasui, D. H., Schroeder, D. I., Dunaway, K., et al. (2011). MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. Neurobiology of Diseases, 43(1), 190–200. doi:10.​1016/​j.​nbd.​2011.​03.​011.
Skene, P. J., Illingworth, R. S., Webb, S., Kerr, A. R., James, K. D., Turner, D. J., et al. (2010). Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Molecular Cell, 37(4), 457–468. doi:10.​1016/​j.​molcel.​2010.​01.​030.PubMed
Smrt, R. D., Eaves-Egenes, J., Barkho, B. Z., Santistevan, N. J., Zhao, C., Aimone, J. B., et al. (2007). Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons. Neurobiology of Diseases, 27(1), 77–89. doi:10.​1016/​j.​nbd.​2007.​04.​005.
Squillaro, T., Alessio, N., Cipollaro, M., Melone, M. A., Hayek, G., Renieri, A., et al. (2012). Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: New perspective for Rett syndrome. Molecular Biology of the Cell, 23(8), 1435–1445. doi:10.​1091/​mbc.​E11-09-0784.PubMedCentralPubMed
Stettner, G. M., Huppke, P., Gartner, J., Richter, D. W., & Dutschmann, M. (2008). Disturbances of breathing in Rett syndrome: Results from patients and animal models. Advances in Experimental Medicine and Biology, 605, 503–507. doi:10.​1007/​978-0-387-73693-8_​88.PubMed
Stuss, D. P., Cheema, M., Ng, M. K., de Paz, A. M., Williamson, B., Missiaen, K., et al. (2013). Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain. Nucleic Acids Research, 41(9), 4888–4900. doi:10.​1093/​nar/​gkt213.PubMedCentralPubMed
Subramaniam, B., Naidu, S., & Reiss, A. L. (1997). Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa. Neurology, 48(2), 399–407.PubMed
Suter, B., Treadwell-Deering, D., Zoghbi, H. Y., Glaze, D. G., & Neul, J. L. (2013). Brief report: MECP2 mutations in people without Rett syndrome. Journal of Autism and Developmental Disorders,. doi:10.​1007/​s10803-013-1902-z.
Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N. E., Martinowich, K., et al. (2009). Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proceedings of the National Academy of Sciences USA, 106(12), 4882–4887. doi:10.​1073/​pnas.​0811648106.
Tejada, M. I., Penagarikano, O., Rodriguez-Revenga, L., Martinez-Bouzas, C., Garcia, B., Badenas, C., et al. (2006). Screening for MECP2 mutations in Spanish patients with an unexplained mental retardation. Clinical Genetics, 70(2), 140–144. doi:10.​1111/​j.​1399-0004.​2006.​00647.​x.PubMed
Thambirajah, A. A., Eubanks, J. H., & Ausio, J. (2009). MeCP2 post-translational regulation through PEST domains: Two novel hypotheses: potential relevance and implications for Rett syndrome. BioEssays, 31(5), 561–569. doi:10.​1002/​bies.​200800220.PubMed
Thatcher, K. N., & LaSalle, J. M. (2006). Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics, 1(1), 24–31.PubMedCentralPubMed
Tochiki, K. K., Cunningham, J., Hunt, S. P., & Geranton, S. M. (2012). The expression of spinal methyl-CpG-binding protein 2, DNA methyltransferases and histone deacetylases is modulated in persistent pain states. Molecular Pain, 8, 14. doi:10.​1186/​1744-8069-8-14.PubMedCentralPubMed
Trinidad, J. C., Thalhammer, A., Specht, C. G., Lynn, A. J., Baker, P. R., Schoepfer, R., et al. (2008). Quantitative analysis of synaptic phosphorylation and protein expression. Molecular and Cellular Proteomics, 7(4), 684–696. doi:10.​1074/​mcp.​M700170-MCP200.PubMed
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., et al. (2009). Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proceedings of the National Academy of Sciences USA, 106(6), 2029–2034. doi:10.​1073/​pnas.​0812394106.
Tsujimura, K., Abematsu, M., Kohyama, J., Namihira, M., & Nakashima, K. (2009). Neuronal differentiation of neural precursor cells is promoted by the methyl-CpG-binding protein MeCP2. Experimental Neurology, 219(1), 104–111. doi:10.​1016/​j.​expneurol.​2009.​05.​001.PubMed
Tudor, M., Akbarian, S., Chen, R. Z., & Jaenisch, R. (2002). Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proceedings of the National Academy of Sciences USA, 99(24), 15536–15541. doi:10.​1073/​pnas.​242566899.
Tunc-Ozcan, E., Ullmann, T. M., Shukla, P. K., & Redei, E. E. (2013). Low-dose thyroxine attenuates autism-associated adverse effects of fetal alcohol in male offspring’s social behavior and hippocampal gene expression. Alcoholism, Clinical and Experimental Research,. doi:10.​1111/​acer.​12183.PubMed
Vanhala, R., Gaily, E., Paetau, A., & Riikonen, R. (1998). Pons tumour behind a phenotypic Rett syndrome presentation. Developmental Medicine and Child Neurology, 40(12), 836–839.PubMed
Vecsler, M., Ben Zeev, B., Nudelman, I., Anikster, Y., Simon, A. J., Amariglio, N., et al. (2011). Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations. PLoS ONE, 6(6), e20733. doi:10.​1371/​journal.​pone.​0020733.PubMedCentralPubMed
Volkmann, I., Kumarswamy, R., Pfaff, N., Fiedler, J., Dangwal, S., Holzmann, A., et al. (2013). MicroRNA-mediated epigenetic silencing of Sirtuin1 contributes to impaired angiogenic responses. Circulation Research,. doi:10.​1161/​CIRCRESAHA.​113.​301702.PubMed
Wada, R., Akiyama, Y., Hashimoto, Y., Fukamachi, H., & Yuasa, Y. (2010). miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. International Journal of Cancer, 127(5), 1106–1114. doi:10.​1002/​ijc.​25126.
Wang, Y., Liu, C., Guo, Q. L., Yan, J. Q., Zhu, X. Y., Huang, C. S., et al. (2011). Intrathecal 5-azacytidine inhibits global DNA methylation and methyl-CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury. Brain Research, 1418, 64–69. doi:10.​1016/​j.​brainres.​2011.​08.​040.PubMed
Wang, I. T., Reyes, A. R., & Zhou, Z. (2013a). Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation. Neurobiology of Diseases, 58C, 3–12. doi:10.​1016/​j.​nbd.​2013.​04.​020.
Wang, J. T., Wu, T. T., Bai, L., Ding, L., Hao, M., & Wang, Y. (2013b). Effect of folate in modulating the expression of DNA methyltransferase 1 and methyl-CpG-bingding protein 2 in cervical cancer cell lines. Zhonghua Liu Xing Bing Xue Za Zhi, 34(2), 173–177.PubMed
Warita, K., Mitsuhashi, T., Ohta, K., Suzuki, S., Hoshi, N., Miki, T., et al. (2013). Gene expression of epigenetic regulatory factors related to primary silencing mechanism is less susceptible to lower doses of bisphenol A in embryonic hypothalamic cells. Journal of Toxicological Sciences, 38(2), 285–289.PubMed
Watson, P., Black, G., Ramsden, S., Barrow, M., Super, M., Kerr, B., et al. (2001). Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. Journal of Medical Genetics, 38(4), 224–228.PubMedCentralPubMed
Weaving, L. S., Christodoulou, J., Williamson, S. L., Friend, K. L., McKenzie, O. L., Archer, H., et al. (2004). Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. American Journal of Human Genetics, 75(6), 1079–1093. doi:10.​1086/​426462.PubMedCentralPubMed
Weaving, L. S., Williamson, S. L., Bennetts, B., Davis, M., Ellaway, C. J., Leonard, H., et al. (2003). Effects of MECP2 mutation type, location and X-inactivation in modulating Rett syndrome phenotype. American Journal of Medical Genetics: Part A, 118A(2), 103–114. doi:10.​1002/​ajmg.​a.​10053.
Wither, R. G., Lang, M., Zhang, L., & Eubanks, J. H. (2013). Regional MeCP2 expression levels in the female MeCP2-deficient mouse brain correlate with specific behavioral impairments. Experimental Neurology, 239, 49–59. doi:10.​1016/​j.​expneurol.​2012.​09.​005.PubMed
Woodyatt, G. C., & Ozanne, A. E. (1993). A longitudinal study of cognitive skills and communication behaviours in children with Rett syndrome. Journal of Intellectual Disability Research, 37(Pt 4), 419–435.PubMed
Wu, H., Tao, J., Chen, P. J., Shahab, A., Ge, W., Hart, R. P., et al. (2010). Genome-wide analysis reveals methyl-CpG-binding protein 2-dependent regulation of microRNAs in a mouse model of Rett syndrome. Proceedings of the National Academy of Sciences USA, 107(42), 18161–18166. doi:10.​1073/​pnas.​1005595107.
Xinhua, B., Shengling, J., Fuying, S., Hong, P., Meirong, L., & Wu, X. R. (2008). X chromosome inactivation in Rett Syndrome and its correlations with MECP2 mutations and phenotype. Journal of Child Neurology, 23(1), 22–25. doi:10.​1177/​0883073807307077​.
Xu, X., Jin, H., Liu, Y., Liu, L., Wu, Q., Guo, Y., et al. (2012a). The expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomas. Diagnostic Pathology, 7, 33. doi:10.​1186/​1746-1596-7-33.PubMedCentralPubMed
Xu, X., Xu, Q., Zhang, Y., Zhang, X., Cheng, T., Wu, B., et al. (2012b). A case report of Chinese brothers with inherited MECP2-containing duplication: Autism and intellectual disability, but not seizures or respiratory infections. BMC Medical Genetics, 13, 75. doi:10.​1186/​1471-2350-13-75.PubMedCentralPubMed
Yaqinuddin, A., Abbas, F., Naqvi, S. Z., Bashir, M. U., Qazi, R., & Qureshi, S. A. (2008). Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes. Bioscience Reports, 28(6), 319–326. doi:10.​1042/​BSR20080032.PubMed
Yasui, D. H., Gonzales, M. L., Aflatooni, J. O., Crary, F. K., Hu, D. J., Gavino, B. J., et al. (2014). Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Human Molecular Genetics,. doi:10.​1093/​hmg/​ddt640.PubMed
Yasui, D. H., Peddada, S., Bieda, M. C., Vallero, R. O., Hogart, A., Nagarajan, R. P., et al. (2007). Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proceedings of the National Academy of Sciences USA, 104(49), 19416–19421. doi:10.​1073/​pnas.​0707442104.
Young, D. J., Bebbington, A., Anderson, A., Ravine, D., Ellaway, C., Kulkarni, A., et al. (2008). The diagnosis of autism in a female: Could it be Rett syndrome? European Journal of Pediatrics, 167(6), 661–669. doi:10.​1007/​s00431-007-0569-x.PubMed
Young, J. I., Hong, E. P., Castle, J. C., Crespo-Barreto, J., Bowman, A. B., Rose, M. F., et al. (2005). Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proceedings of the National Academy of Sciences USA, 102(49), 17551–17558. doi:10.​1073/​pnas.​0507856102.
Yu, D., Sakurai, F., & Corey, D. R. (2011). Clonal Rett Syndrome cell lines to test compounds for activation of wild-type MeCP2 expression. Bioorganic & Medicinal Chemistry Letters, 21(18), 5202–5205. doi:10.​1016/​j.​bmcl.​2011.​07.​053.
Zanella, S., Mebarek, S., Lajard, A. M., Picard, N., Dutschmann, M., & Hilaire, G. (2008). Oral treatment with desipramine improves breathing and life span in Rett syndrome mouse model. Respiratory Physiology & Neurobiology, 160(1), 116–121. doi:10.​1016/​j.​resp.​2007.​08.​009.
Zhou, P., Lu, Y., & Sun, X. H. (2011). Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2. Molecular Vision, 17, 2717–2723.PubMedCentralPubMed
Zoll, B., Huppke, P., Wessel, A., Bartels, I., & Laccone, F. (2004). Fetal alcohol syndrome in association with Rett syndrome. Genetic Counseling, 15(2), 207–212.PubMed
Metadata
Title
Rett Syndrome and MeCP2
Authors
Vichithra R. B. Liyanage
Mojgan Rastegar
Publication date
01-06-2014
Publisher
Springer US
Published in
NeuroMolecular Medicine / Issue 2/2014
Print ISSN: 1535-1084
Electronic ISSN: 1559-1174
DOI
https://doi.org/10.1007/s12017-014-8295-9

Other articles of this Issue 2/2014

NeuroMolecular Medicine 2/2014 Go to the issue

Original Paper

Correction of the Middle Eastern M712T Mutation Causing GNE Myopathy by Trans-Splicing

Original Paper

Altered Cerebrospinal Fluid Levels of Amyloid β and Amyloid Precursor-Like Protein 1 Peptides in Down’s Syndrome

Original Paper

Neuronal and Astroglial TGFβ-Smad3 Signaling Pathways Differentially Regulate Dendrite Growth and Synaptogenesis

Review Paper

Oxidative Stress-Induced Signaling Pathways Implicated in the Pathogenesis of Parkinson’s Disease

Original Paper

Deciphering the Roles of Trehalose and Hsp104 in the Inhibition of Aggregation of Mutant Huntingtin in a Yeast Model of Huntington’s Disease

Original Paper

Oct-2 Transcription Factor Binding Activity and Expression Up-Regulation in Rat Cerebral Ischaemia is Associated with a Diminution of Neuronal Damage In Vitro